Impact of Efavirenz Metabolism on Loss to Care in Older HIV+ Africans

BACKGROUND: Efavirenz is commonly used in Africa and is frequently associated with neurocognitive toxicity, which may compromise clinical outcomes. Older individuals are at increased risk for drug toxicity and clinical outcomes may be worse in older age, particularly among those individuals with cyt...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Eur J Drug Metab Pharmacokinet
Main Authors: Torgersen, Jessie, Bellamy, Scarlett L., Ratshaa, Bakgaki, Han, Xiaoyan, Mosepele, Mosepele, Zuppa, Athena F, Vujkovic, Marijana, Steenhoff, Andrew, Bisson, Gregory P., Gross, Robert
Format: Artigo
Sprog:Inglês
Udgivet: 2019
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6420397/
https://ncbi.nlm.nih.gov/pubmed/30168000
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13318-018-0507-5
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker